93 results on '"Brown-Borg H."'
Search Results
2. Longevity in mice: is stress resistance a common factor?
- Author
-
Brown-Borg, H. M.
- Published
- 2006
- Full Text
- View/download PDF
3. Effects of overexpression of growth hormone on T cell activity in transgenic mice
- Author
-
Esquifino, A. I., Arce, A., Alvarez, M. P., Szary, A., Brown-Borg, H., and Bartke, A.
- Published
- 2002
- Full Text
- View/download PDF
4. Glutathione metabolism in long-living Ames dwarf mice
- Author
-
Brown-Borg, H. M. and Rakoczy, S. G.
- Published
- 2005
- Full Text
- View/download PDF
5. Prolonged longevity of hypopituitary dwarf mice
- Author
-
Bartke, A, Brown-Borg, H, Mattison, J, Kinney, B, Hauck, S, and Wright, C
- Published
- 2001
- Full Text
- View/download PDF
6. REDUCED GH SIGNALING ENHANCES THE ABILITY OF AN ORGANISM TO RESPOND TO STRESS
- Author
-
Brown-Borg, H, primary and Rakoczy, S, additional
- Published
- 2018
- Full Text
- View/download PDF
7. The Second International Conference 'Genetics of Aging and Longevity'
- Author
-
Anisimov V. N, Bartke A, Barzilai N, Batin M. A, Blagosklonny M. V, Brown-Borg H, Budovskaya Y, Campisi J, Friguet B, Fraifeld V, Franceschi C, Gems D, Gladyshev V, Gorbunova V, Gudkov A. V, Kennedy B, Konovalenko M, Kraemer B, Moskalev A, Petropoulos I, Pasyukova E, Rattan S, Rogina B, Seluanov A, Shaposhnikov M, Shmookler Reis R, Tavernarakis N, Vijg J, Yashin A. and Zimniak P., Anisimov V. N., Bartke A., Barzilai N., Batin M. A., Blagosklonny M. V., Brown-Borg H., Budovskaya Y., Campisi J., Friguet B., Fraifeld V., Franceschi C., Gems D., Gladyshev V., Gorbunova V., Gudkov A. V., Kennedy B., Konovalenko M., Kraemer B., Moskalev A., Petropoulos I., Pasyukova E., Rattan S., Rogina B., Seluanov A., Shaposhnikov M., Shmookler Reis R., Tavernarakis N., Vijg J., Yashin A., and Zimniak P.
- Published
- 2012
8. The somatotropic axis and longevity in mice
- Author
-
Brown-Borg, H. M., primary
- Published
- 2015
- Full Text
- View/download PDF
9. Growth Hormone Alters the Glutathione S-Transferase and Mitochondrial Thioredoxin Systems in Long-Living Ames Dwarf Mice
- Author
-
Rojanathammanee, L., primary, Rakoczy, S., additional, and Brown-Borg, H. M., additional
- Published
- 2013
- Full Text
- View/download PDF
10. Expression of DNA Methyltransferases Is Influenced by Growth Hormone in the Long-Living Ames Dwarf Mouse In Vivo and In Vitro
- Author
-
Armstrong, V. L., primary, Rakoczy, S., additional, Rojanathammanee, L., additional, and Brown-Borg, H. M., additional
- Published
- 2013
- Full Text
- View/download PDF
11. GH and IGF1: Roles in Energy Metabolism of Long-Living GH Mutant Mice
- Author
-
Brown-Borg, H. M., primary and Bartke, A., additional
- Published
- 2012
- Full Text
- View/download PDF
12. Aging Impairs the Expression of the Catalytic Subunit of Glutamate Cysteine Ligase in Soleus Muscle Under Stress
- Author
-
Chen, C.-n., primary, Brown-Borg, H. M., additional, Rakoczy, S. G., additional, Ferrington, D. A., additional, and Thompson, L. V., additional
- Published
- 2009
- Full Text
- View/download PDF
13. Muscle Disuse: Adaptation of Antioxidant Systems Is Age Dependent
- Author
-
Chen, C.-n., primary, Brown-Borg, H. M., additional, Rakoczy, S. G., additional, and Thompson, L. V., additional
- Published
- 2008
- Full Text
- View/download PDF
14. Peroxisome Proliferator-Activated Receptor Coactivator 1 in Caloric Restriction and Other Models of Longevity
- Author
-
Corton, J. C., primary and Brown-Borg, H. M., additional
- Published
- 2005
- Full Text
- View/download PDF
15. Antiaging Supplement Holds Promise to Halt Age-Related Cognitive Deterioration
- Author
-
Brown-Borg, H. M., primary
- Published
- 2004
- Full Text
- View/download PDF
16. Differential Effects of Light/Dark Recombinant Human Prolactin Administration on the Submaxillary Lymph Nodes and Spleen Activity of Adult Male Mice
- Author
-
Esquifino, A.I., primary, Arce, A., additional, Alvarez, M.P., additional, Chacon, F., additional, Brown-Borg, H., additional, and Bartke, A., additional
- Published
- 2004
- Full Text
- View/download PDF
17. Immune Function in Transgenic Mice Overexpressing Growth Hormone (GH) Releasing Hormone, GH or GH Antagonist
- Author
-
Dialynas, E., primary, Brown-Borg, H., additional, and Bartke, A., additional
- Published
- 1999
- Full Text
- View/download PDF
18. Age-Related Effects of Ectopic Pituitary Transplants on the Activation of Ames Dwarf Mouse Lymphocytes In Vitro
- Author
-
Esquifino, A. I., primary, Szary, A., additional, Brown-Borg, H. M., additional, and Bartke, A., additional
- Published
- 1996
- Full Text
- View/download PDF
19. Assessment of the Primary Adrenal Cortical and Pancreatic Hormone Basal Levels in Relation to Plasma Glucose and Age in the Unstressed Ames Dwarf Mouse
- Author
-
Borg, K. E., primary, Brown-Borg, H. M., additional, and Bartke, A., additional
- Published
- 1995
- Full Text
- View/download PDF
20. Lymphocyte proliferative responses in neonatal pigs with high or low plasma cortisol concentration after stress induced by restraint
- Author
-
Brown-Borg, H. M., primary, Klemcke, H. G., additional, and Blecha, F., additional
- Published
- 1993
- Full Text
- View/download PDF
21. Cardiac contractile function is enhanced in isolated ventricular myocytes from growth hormone transgenic mice.
- Author
-
Colligan, P. B., Brown-Borg, H. M., Duan, J., Ren, B. H., and Ren, J.
- Published
- 2002
22. Catalase expression in delayed and premature aging mouse models
- Author
-
Brown-Borg, H. M. and Rakoczy, S. G.
- Published
- 2000
- Full Text
- View/download PDF
23. Does growth hormone prevent or accelerate aging?
- Author
-
Bartke, A., Brown-Borg, H. M., Bode, A. M., Carlson, J., Hunter, W. S., and Bronson, R. T.
- Published
- 1998
- Full Text
- View/download PDF
24. The second international conference 'genetics of aging and longevity'
- Author
-
Vn, Anisimov, Bartke A, Barzilai N, Ma, Batin, Mv, Blagosklonny, Brown-Borg H, Budovskaya Y, Campisi J, Friguet B, Fraifeld V, Franceschi C, Gems D, Gladyshev V, Gorbunova V, Av, Gudkov, Kennedy B, Konovalenko M, Kraemer B, Moskalev A, and Petropoulos I
25. Elevated metallothionein expression in long-lived species mediates the influence of cadmium accumulation on aging
- Author
-
Paolo Garagnani, Marco Malavolta, Claudia Sala, Mauro Provinciali, Kamil Pabis, Robertina Giacconi, Elisabeth Straka, Ylenia Chiari, Xinna Li, Holly M. Brown-Borg, Teresa G. Valencak, Claudia Gundacker, Karin Nowikovsky, Pabis K., Chiari Y., Sala C., Straka E., Giacconi R., Provinciali M., Li X., Brown-Borg H., Nowikovsky K., Valencak T.G., Gundacker C., Garagnani P., and Malavolta M.
- Subjects
Aging ,media_common.quotation_subject ,Longevity ,chemistry.chemical_element ,Biology ,Kidney ,Mammal ,Mice ,Gene expression ,Metallothionein ,Animals ,Gene ,Maximum life span ,media_common ,Cadmium ,Animal ,Molecular medicine ,Comparative biogerontology ,Cell biology ,chemistry ,Liver ,Original Article ,Geriatrics and Gerontology ,Homeostasis - Abstract
Cadmium (Cd) accumulates with aging and is elevated in long-lived species. Metallothioneins (MTs), small cysteine-rich proteins involved in metal homeostasis and Cd detoxification, are known to be related to longevity. However, the relationship between Cd accumulation, the role of MTs, and aging is currently unclear. Specifically, we do not know if long-lived species evolved an efficient metal stress response by upregulating their MT levels to reduce the toxic effects of environmental pollutants, such as Cd, that accumulate over their longer life span. It is also unknown if the number of MT genes, their expression, or both protect the organisms from potentially damaging effects during aging. To address these questions, we reanalyzed several cross-species studies and obtained data on MT expression and Cd accumulation in long-lived mouse models. We confirmed a relationship between species maximum life span in captive mammals and their Cd content in liver and kidney. We found that although the number of MT genes does not affect longevity, gene expression and protein amount of specific MT paralogs are strongly related to life span in mammals. MT expression rather than gene number may influence the high Cd levels and longevity of some species. In support of this, we found that overexpression of MT-1 accelerated Cd accumulation in mice and that tissue Cd was higher in long-lived mouse strains with high MT expression. We conclude that long-lived species have evolved a more efficient stress response by upregulating the expression of MT genes in presence of Cd, which contributes to elevated tissue Cd levels. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11357-021-00393-3.
- Published
- 2021
26. Interventions to Slow Aging in Humans: Are We Ready?
- Author
-
Jan Vijg, John J. Kopchick, Brian K. Kennedy, Andrzej Bartke, Frank Madeo, Calogero Caruso, John M. Sedivy, Karl Lenhard Rudolph, Giuseppe Passarino, Manlio Vinciguerra, Nir Barzilai, Gerald S. Shadel, Stephen R. Spindler, G Lepperdinger, Cynthia Kenyon, James R. Mitchell, David A. Sinclair, Samuel Klein, Tyler J. Curiel, David Gems, Donald K. Ingram, Mario G. Mirisola, Valter D. Longo, Luigi Fontana, Adam Antebi, Rafael de Cabo, Claudio Franceschi, Holly M. Brown-Borg, Yousin Suh, Thomas E. Johnson, Longo, V., Antebi, A., Bartke, A., Barzilai, N., Brown-Borg, H., Caruso, C., Curiel, T., de Cabo, R., Franceschi, C., Gems, D., Ingram, D., Johnson, T., Kennedy, B., Kenyon, C., Klein, S., Kopchick, J., Lepperdinger, G., Madeo, F., Mirisola, M., Mitchell, J., Passarino, G., Rudolph, K., Sedivy, J., Shadel, G., Sinclair, D., Spindler, S., Suh, Y., Vijg, J., Vinciguerra, M., and Fontana, L.
- Subjects
Gerontology ,Aging ,Disease onset ,Prescription Drugs ,Longevity ,Psychological intervention ,Reviews ,Biology ,AMP-Activated Protein Kinases ,Growth hormone ,Anti-aging ,Centenarians ,Dietary restriction ,Lifespan studies ,Longevity gene ,Longevity regulation ,Cell Biology ,Dietary interventions ,Biological Factors ,Mice ,longevity gene ,Settore BIO/13 - Biologia Applicata ,Animals ,Humans ,Sirtuins ,Protein restriction ,Centenarian ,Insulin-Like Growth Factor I ,Lifespan studie ,Caloric Restriction ,Settore MED/04 - Patologia Generale ,Geroscience ,Gene targets ,Ribosomal Protein S6 Kinases ,TOR Serine-Threonine Kinases ,anti-aging ,dietary restriction ,lifespan studies ,centenarians ,longevity regulation ,aging ,3. Good health ,Diet ,Enzyme Activation ,Gene Expression Regulation ,Growth Hormone ,Genetics of aging ,Signal Transduction - Abstract
The workshop entitled 'Interventions to Slow Aging in Humans: Are We Ready?' was held in Erice, Italy, on October 8-13, 2013, to bring together leading experts in the biology and genetics of aging and obtain a consensus related to the discovery and development of safe interventions to slow aging and increase healthy lifespan in humans. There was consensus that there is sufficient evidence that aging interventions will delay and prevent disease onset for many chronic conditions of adult and old age. Essential pathways have been identified, and behavioral, dietary, and pharmacologic approaches have emerged. Although many gene targets and drugs were discussed and there was not complete consensus about all interventions, the participants selected a subset of the most promising strategies that could be tested in humans for their effects on healthspan. These were: (i) dietary interventions mimicking chronic dietary restriction (periodic fasting mimicking diets, protein restriction, etc.); (ii) drugs that inhibit the growth hormone/IGF-I axis; (iii) drugs that inhibit the mTOR-S6K pathway; or (iv) drugs that activate AMPK or specific sirtuins. These choices were based in part on consistent evidence for the pro-longevity effects and ability of these interventions to prevent or delay multiple age-related diseases and improve healthspan in simple model organisms and rodents and their potential to be safe and effective in extending human healthspan. The authors of this manuscript were speakers and discussants invited to the workshop. The following summary highlights the major points addressed and the conclusions of the meeting.
- Published
- 2015
27. Aging and Longevity in Animal Models and Humans
- Author
-
Laura Celani, Claudio Franceschi, Daniela Monti, Catia Lanzarini, Elisa Cevenini, Federica Sevini, Francesco Lescai, Stella Lukas, Elena Bellavista, Miriam Capri, Stefano Salvioli, Paolo Tieri, SELL C. LORENZINI A. BROWN-BORG H, Capri M., Salvioli S., Cevenini E, Celani L, Sevini F, Bellavista E, Lanzarini C., Lukas S., Monti D., Tieri P., Lescai F., and Franceschi C.
- Subjects
Evolutionary biology ,Process (engineering) ,Human longevity ,media_common.quotation_subject ,Longevity ,Identification (biology) ,Context (language use) ,Nuclear factor κb ,Biology ,Healthy aging ,Aging longevity animal models p66shc PON1 nuclear factor-κB TP53 SIRT1 insulin-like growth factor I caloric restriction ,GeneralLiterature_MISCELLANEOUS ,media_common - Abstract
How many animal models are adequate to study human aging? Aging is an adaptive process performed by an integrated panel of evolutionarily selected mechanisms aimed at maintaining soma integrity. The possibility of extrapolating results from animal models to human beings has to be addressed in an ecological context. Model systems fit basic requirements of scientific research, and experimental animals show a series of advantages for the study of aging and longevity in humans. However, animal models have intrinsic constraints because they are artificial: Humans are not inbred and live in different conditions from both an environmental and a socio-anthropological-cultural point of view. Even if research on aging and longevity has been performed primarily in model systems such as yeast, worms, and flies, results obtained in humans are not only of basic importance but are also largely unexpected, probably because of the peculiar characteristics of humans (protected environment, culture, economic conditions, stochasticity). In some cases, studies in animal models or humans have led to analogous results, largely because basic mechanisms involved in aging have been conserved throughout evolution. In other cases, results are different or even opposite, as is described in this chapter. Animal models are often not sufficiently adequate for the study of human longevity, but their usefulness in achieving knowledge at different levels (molecular, cellular, physiological, behavioral) is unquestionable. Thus, it seems that the concomitant and integrated use of ad hoc models, also comparing different species, together with new in silico and high throughput strategies, will be the general framework within which studies on human aging and longevity should be performed to accelerate the identification of new determinants of healthy aging and longevity.
- Published
- 2009
28. The second international conference 'genetics of aging and longevity'
- Author
-
Mikhail V. Blagosklonny, Vera Gorbunova, Vadim E. Fraifeld, Claudio Franceschi, Andrei V. Gudkov, Andrzej Bartke, Suresh I. S. Rattan, Robert J. Shmookler Reis, David Gems, Yelena V. Budovskaya, Jan Vijg, Andrei Seluanov, Vadim N. Gladyshev, Vladimir N. Anisimov, Nir Barzilai, Maria Konovalenko, Piotr Zimniak, Nektarios Tavernarakis, Elena G. Pasyukova, Holly M. Brown-Borg, Blanka Rogina, Brett A. Kennedy, Anatoli I. Yashin, M. A. Batin, Brian Kraemer, Mikhail Shaposhnikov, Isabelle Petropoulos, Alexey Moskalev, Bertrand Friguet, Judith Campisi, Molecular Biology and Microbial Food Safety (SILS, FNWI), Anisimov V.N., Bartke A., Barzilai N., Batin M.A., Blagosklonny M.V., Brown-Borg H., Budovskaya Y., Campisi J., Friguet B., Fraifeld V., Franceschi C., Gems D., Gladyshev V., Gorbunova V., Gudkov A.V., Kennedy B., Konovalenko M., Kraemer B., Moskalev A., Petropoulos I., Pasyukova E., Rattan S., Rogina B., Seluanov A., Shaposhnikov M., Shmookler Reis R., Tavernarakis N., Vijg J., Yashin A., and Zimniak P.
- Subjects
Geriatrics ,Gerontology ,Aging ,medicine.medical_specialty ,business.industry ,Biological age ,media_common.quotation_subject ,Longevity ,Genetics of aging ,Cell Biology ,Meeting Report ,Longevity genes ,Life expectancy ,Medicine ,Identification (biology) ,LONGEVITY ,business ,media_common - Abstract
The ongoing revolution in aging research was manifested by the Second International Conference "Genetics of Aging and Longevity" (Moscow, April 22-25, 2012). The Conference goal was to identify the most promising areas of genetics, life expectancy, and aging, including: the search for longevity genes; the search for pharmacological agents that slow aging; the identification of biological age markers; and the identification of mechanisms by which the environment influences the aging rate.
29. Disrupted HSF1 regulation in normal and exceptional brain aging.
- Author
-
Trivedi R, Knopf B, Rakoczy S, Manocha GD, Brown-Borg H, and Jurivich DA
- Subjects
- Mice, Animals, Heat Shock Transcription Factors metabolism, Aging metabolism, Brain metabolism, DNA-Binding Proteins genetics, Transcription Factors genetics
- Abstract
Brain aging is a major risk factor for cognitive diseases such as Alzheimer's disease (AD) and vascular dementia. The rate of aging and age-related pathology are modulated by stress responses and repair pathways that gradually decline with age. However, recent reports indicate that exceptional longevity sustains and may even enhance the stress response. Whether normal and exceptional aging result in either attenuated or enhanced stress responses across all organs is unknown. This question arises from our understanding that biological age differs from chronological age and evidence that the rate of aging varies between organs. Thus, stress responses may differ between organs and depend upon regenerative capacity and ability to manage damaged proteins and proteotoxicity. To answer these questions, we assessed age-dependent changes in brain stress responses with normally aged wild type and long-lived Dwarf mice. Results from this study show that normal aging unfavorably impacts activation of the brain heat shock (HS) axis with key changes noted in the transcription factor, HSF1, and its regulation. Exceptional aging appears to preserve and strengthen many elements of HSF1 activation in the brain. These results support the possibility that reconstitution of aging brain stress responses requires a multi-factorial approach that addresses HSF1 protein levels, its DNA binding, and regulatory elements such as phosphorylation and protein interactions., (© 2023. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
30. Neurobiology of Aging: New Insights From Across the Research Spectrum.
- Author
-
Villeda S, Brown-Borg H, and Anderson R
- Subjects
- Neurobiology
- Published
- 2023
- Full Text
- View/download PDF
31. The methyltransferase enzymes KMT2D, SETD1B, and ASH1L are key mediators of both metabolic and epigenetic changes during cellular senescence.
- Author
-
Nacarelli T, Azar A, Potnis M, Johannes G, Mell J, Johnson FB, Brown-Borg H, Noguchi E, and Sell C
- Subjects
- Fibroblasts metabolism, Glycolysis, Methionine metabolism, Sirolimus pharmacology, Cellular Senescence genetics, Epigenesis, Genetic
- Abstract
Cellular senescence is a terminal cell fate characterized by growth arrest and a metabolically active state characterized by high glycolytic activity. Human fibroblasts were placed in a unique metabolic state using a combination of methionine restriction (MetR) and rapamycin (Rapa). This combination induced a metabolic reprogramming that prevented the glycolytic shift associated with senescence. Surprisingly, cells treated in this manner did not undergo senescence but continued to divide at a slow rate even at high passage, in contrast with either Rapa treatment or MetR, both of which extended life span but eventually resulted in growth arrest. Transcriptome-wide analysis revealed a coordinated regulation of metabolic enzymes related to one-carbon metabolism including three methyltransferase enzymes (KMT2D, SETD1B, and ASH1L), key enzymes for both carnitine synthesis and histone modification. These enzymes appear to be involved in both the metabolic phenotype of senescent cells and the chromatin changes required for establishing the senescence arrest. Targeting one of these enzymes, ASH1L, produced both a glycolytic shift and senescence, providing proof of concept. These findings reveal a mechanistic link between a major metabolic hallmark of senescence and nuclear events required for senescence.
- Published
- 2022
- Full Text
- View/download PDF
32. Mutations Affecting Mammalian Aging: GH and GHR vs IGF-1 and Insulin.
- Author
-
Bartke A and Brown-Borg H
- Abstract
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
- Published
- 2021
- Full Text
- View/download PDF
33. Augmentation of the heat shock axis during exceptional longevity in Ames dwarf mice.
- Author
-
Trivedi R, Knopf B, Tripathi JK, Rakoczy S, Manocha GD, Brown-Borg H, and Jurivich DA
- Subjects
- Aging genetics, Animals, Mice, Phosphorylation, Proteostasis, Heat-Shock Response, Longevity genetics
- Abstract
How the heat shock axis, repair pathways, and proteostasis impact the rate of aging is not fully understood. Recent reports indicate that normal aging leads to a 50% change in several regulatory elements of the heat shock axis. Most notably is the age-dependent enhancement of inhibitory signals associated with accumulated heat shock proteins and hyper-acetylation associated with marked attenuation of heat shock factor 1 (HSF1)-DNA binding activity. Because exceptional longevity is associated with increased resistance to stress, this study evaluated regulatory check points of the heat shock axis in liver extracts from 12 months and 24 months long-lived Ames dwarf mice and compared these findings with aging wild-type mice. This analysis showed that 12M dwarf and wild-type mice have comparable stress responses, whereas old dwarf mice, unlike old wild-type mice, preserve and enhance activating elements of the heat shock axis. Old dwarf mice thwart negative regulation of the heat shock axis typically observed in usual aging such as noted in HSF1 phosphorylation at Ser307 residue, acetylation within its DNA binding domain, and reduction in proteins that attenuate HSF1-DNA binding. Unlike usual aging, dwarf HSF1 protein and mRNA levels increase with age and further enhance by stress. Together these observations suggest that exceptional longevity is associated with compensatory and enhanced HSF1 regulation as an adaptation to age-dependent forces that otherwise downregulate the heat shock axis., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
34. Elevated metallothionein expression in long-lived species mediates the influence of cadmium accumulation on aging.
- Author
-
Pabis K, Chiari Y, Sala C, Straka E, Giacconi R, Provinciali M, Li X, Brown-Borg H, Nowikovsky K, Valencak TG, Gundacker C, Garagnani P, and Malavolta M
- Subjects
- Aging genetics, Animals, Kidney, Liver, Mice, Cadmium toxicity, Metallothionein genetics
- Abstract
Cadmium (Cd) accumulates with aging and is elevated in long-lived species. Metallothioneins (MTs), small cysteine-rich proteins involved in metal homeostasis and Cd detoxification, are known to be related to longevity. However, the relationship between Cd accumulation, the role of MTs, and aging is currently unclear. Specifically, we do not know if long-lived species evolved an efficient metal stress response by upregulating their MT levels to reduce the toxic effects of environmental pollutants, such as Cd, that accumulate over their longer life span. It is also unknown if the number of MT genes, their expression, or both protect the organisms from potentially damaging effects during aging. To address these questions, we reanalyzed several cross-species studies and obtained data on MT expression and Cd accumulation in long-lived mouse models. We confirmed a relationship between species maximum life span in captive mammals and their Cd content in liver and kidney. We found that although the number of MT genes does not affect longevity, gene expression and protein amount of specific MT paralogs are strongly related to life span in mammals. MT expression rather than gene number may influence the high Cd levels and longevity of some species. In support of this, we found that overexpression of MT-1 accelerated Cd accumulation in mice and that tissue Cd was higher in long-lived mouse strains with high MT expression. We conclude that long-lived species have evolved a more efficient stress response by upregulating the expression of MT genes in presence of Cd, which contributes to elevated tissue Cd levels., (© 2021. American Aging Association.)
- Published
- 2021
- Full Text
- View/download PDF
35. Multifactorial Attenuation of the Murine Heat Shock Response With Age.
- Author
-
Jurivich DA, Manocha GD, Trivedi R, Lizakowski M, Rakoczy S, and Brown-Borg H
- Subjects
- Acetylation, Age Factors, Animals, Cell Cycle Checkpoints, Liver metabolism, Mice, Oxidative Stress, Phosphorylation, Protein Processing, Post-Translational, Proteostasis, RNA, Messenger metabolism, Stress, Physiological, Transcriptional Activation, Heat Shock Transcription Factors metabolism, Heat-Shock Response
- Abstract
Age-dependent perturbation of the cellular stress response affects proteostasis and other key functions relevant to cellular action and survival. Central to age-related changes in the stress response is loss of heat shock factor 1 (HSF1)-DNA binding and transactivation properties. This report elucidates how age alters different checkpoints of HSF1 activation related to posttranslational modification and protein interactions. When comparing liver extracts from middle aged (12 M) and old (24 M) mice, significant differences are found in HSF1 phosphorylation and acetylation. HSF1 protein levels and messenger RNA decline with age, but its protein levels are stress-inducible and exempt from age-dependent changes. This surprising adaptive change in the stress response has additional implications for aging and chronic physiological stress that might explain an age-dependent dichotomy of HSF1 protein levels that are low in neurodegeneration and elevated in cancer., (© The Author(s) 2019. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2020
- Full Text
- View/download PDF
36. The somatotropic axis and longevity in mice.
- Author
-
Brown-Borg HM
- Subjects
- Aging physiology, Animals, Fibroblast Growth Factors physiology, Mice, Mice, Knockout, Models, Animal, Pituitary Gland, Anterior metabolism, Pituitary Hormones, Anterior physiology, Receptors, Somatomedin physiology, Signal Transduction, Growth Hormone physiology, Insulin-Like Growth Factor I physiology, Longevity physiology
- Abstract
The somatotropic signaling pathway has been implicated in aging and longevity studies in mice and other species. The physiology and lifespans of a variety of mutant mice, both spontaneous and genetically engineered, have contributed to our current understanding of the role of growth hormone and insulin-like growth factor I on aging-related processes. Several other mice discovered to live longer than their wild-type control counterparts also exhibit differences in growth factor levels; however, the complex nature of the phenotypic changes in these animals may also impact lifespan. The somatotropic axis impacts several pathways that dictate insulin sensitivity, nutrient sensing, mitochondrial function, and stress resistance as well as others that are thought to be involved in lifespan regulation., (Copyright © 2015 the American Physiological Society.)
- Published
- 2015
- Full Text
- View/download PDF
37. Acquisition of steady-state operant behavior in long-living Ames Dwarf mice.
- Author
-
Derenne A, Brown-Borg H, Feltman K, Corbett G, and Lackman S
- Subjects
- Age Factors, Analysis of Variance, Animals, Disease Models, Animal, Dwarfism genetics, Homeodomain Proteins genetics, Longevity physiology, Mice, Mice, Mutant Strains, Mutation genetics, Reinforcement Schedule, Reinforcement, Psychology, Conditioning, Operant physiology, Dwarfism physiopathology, Longevity genetics
- Abstract
Ames dwarf mice have a Prop-1 mutation that has been identified with increased levels of IGF-I in the central nervous system, upregulation of neuroprotective systems, and increased lifespan. To elucidate the behavioral effects of the Prop-1 mutation, 8 Ames dwarf and 7 normal mice (all of whom were 8 months of age or younger) were compared on a differential-reinforcement-of-low-rate-of-responding schedule of reinforcement and a matching-to-sample task. On both tasks, nosepokes were reinforced with access to a saccharin solution. Comparisons were based on several measures of behavioral efficiency: pause durations, intertrial intervals, and numbers of responses. Ames dwarf mice were generally less efficient than normal mice. One possible cause of this outcome is that relatively young Ames dwarf mice show less cognitive development than age-matched normal mice., (Copyright © 2011 Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
38. The hippocampus of Ames dwarf mice exhibits enhanced antioxidative defenses following kainic acid-induced oxidative stress.
- Author
-
Sharma S, Rakoczy S, Dahlheimer K, and Brown-Borg H
- Subjects
- Aging metabolism, Animals, Excitatory Amino Acid Agonists pharmacology, Glutathione Reductase metabolism, Glutathione Transferase metabolism, Hippocampus drug effects, Lipid Peroxidation drug effects, Male, Mice, Mice, Mutant Strains, Models, Animal, Oxidative Stress physiology, Glutathione metabolism, Glutathione Disulfide metabolism, Glutathione Peroxidase metabolism, Hippocampus metabolism, Kainic Acid pharmacology, NF-E2-Related Factor 2 metabolism, Oxidative Stress drug effects
- Abstract
Introduction: The vulnerability of the hippocampus to the effects of aging has been found to be associated with a decline in growth hormone/insulin like growth factor-1 (GH/IGF-1), and an increase in oxidative stress. We have evidence that long-living GH-deficient Ames dwarf mice have enhanced antioxidant protection in the periphery but the protection in the central nervous system is less clear., Material and Methods: In the present study, we evaluated the antioxidative defense enzyme status in the hippocampus of Ames dwarf and wild type mice at 3, 12 and 24 months of age and examined the ability of each genotype to resist kainic acid-induced (KA) oxidative stress. An equiseizure concentration of KA was administered such that both genotypes responded with similar seizure scores and lipid peroxidation., Results: We found that GH-sufficient wild type mice showed an increase in oxidative stress as indicated by the reduced ratio of glutathione: glutathione disulfide following KA injection while this ratio was maintained in GH-deficient Ames dwarf mice. In addition, glutathione peroxidase activity (GPx) as well as GPx1 mRNA expression was enhanced in KA-injected Ames dwarf mice but decreased in wild type mice. There was no induction of Nrf-2 (an oxidative stress-induced transcription factor) gene expression in Ames dwarf mice following KA further suggesting maintenance of antioxidant defense in GH-deficiency under oxidative stress conditions., Discussion: Therefore, based on equiseizure administration of KA, Ames dwarf mice have an enhanced antioxidant defense capacity in the hippocampus similar to that observed in the periphery. This improved defense capability in the brain is likely due to increased GPx availability in Ames mice and may contribute to their enhanced longevity., (Copyright © 2010 Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
39. Assessment of spatial memory in mice.
- Author
-
Sharma S, Rakoczy S, and Brown-Borg H
- Subjects
- Animals, Hippocampus physiology, Humans, Long-Term Potentiation physiology, Memory Disorders diagnosis, Memory Disorders physiopathology, Memory Disorders prevention & control, Mice, Aging physiology, Maze Learning physiology, Memory physiology, Spatial Behavior physiology
- Abstract
Improvements in health care have greatly increased life span in the United States. The focus is now shifting from physical well-being to improvement in mental well-being or maintenance of cognitive function in old age. It is known that elderly people suffer from cognitive impairment, even without neurodegeneration, as a part of 'normal aging'. This 'age-associated memory impairment' (AAMI), can have a devastating impact on the social and economic life of an individual as well as the society. Scientists have been experimenting to find methods to prevent the memory loss associated with aging. The major factor involved in these experiments is the use of animal models to assess hippocampal-based spatial memory. This review describes the different types of memory including hippocampal-based memory that is vulnerable to aging. A detailed overview of various behavioral paradigms used to assess spatial memory including the T-maze, radial maze, Morris water maze, Barnes maze and others is presented. The review also describes the molecular basis of memory in hippocampus called as 'long-term potentiation'. The advantages and limitations of the behavioral models in assessing memory and the link to the long-term potentiation are discussed. This review should assist investigators in choosing suitable methods to assess spatial memory in mice., (Copyright © 2010 Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
40. Effect of dopaminergic neurotoxin MPTP/MPP+ on coenzyme Q content.
- Author
-
Dhanasekaran M, Karuppagounder SS, Uthayathas S, Wold LE, Parameshwaran K, Jayachandra Babu R, Suppiramaniam V, and Brown-Borg H
- Subjects
- Animals, Cell Line, Tumor, Cerebellum drug effects, Cerebellum enzymology, Cerebral Cortex drug effects, Cerebral Cortex enzymology, Chromatography, High Pressure Liquid, Humans, Mice, Mice, Inbred C57BL, Pons drug effects, Pons enzymology, Ubiquinone analysis, 1-Methyl-4-phenylpyridinium toxicity, Dopamine Agents toxicity, MPTP Poisoning enzymology, MPTP Poisoning etiology, Ubiquinone metabolism
- Abstract
Coenzyme Q10, an endogenous lipophilic antioxidant, plays an indispensable role in ATP synthesis. The therapeutic value of coenzyme Q10 in Parkinson's disease and other neurodegenerative disorders is still being tested and the preliminary results are promising. The 1-methyl-4-phenyl-1, 2, 3, 6 tetrahydropyridine (MPTP)-treated mouse is a valid and accepted animal model for Parkinson's disease. 1-methyl-4-phenylpyridinium (MPP(+)) is an active toxic metabolite of MPTP. MPP(+) and MPTP are known to induce oxidative stress and mitochondrial dysfunction. However, the effect of MPP(+) and MPTP on coenzyme Q is not clearly understood. The present study investigated the in vitro and in vivo effect of MPP(+) and MPTP on coenzyme Q content. Coenzyme Q content was measured using HPLC-UV detection methods. In the in vitro studies, MPP(+) (0-50 microM) was incubated with SH-SY5Y human neuroblastoma cells and NG-108-15 (mouse/rat, neuroblastomaxglioma hybrid) cells. MPP(+) concentration dependently increased coenzyme Q10 content in SH-SY5Y cells. In NG-108-15 cells, MPP(+) concentration dependently increased both coenzyme Q9 and Q10 content. In the in vivo study, mice were administered with MPTP (30 mg/kg, twice 16 h apart) and sacrificed one week after the last administration. Administration of MPTP to mice significantly increased coenzyme Q9 and coenzyme Q10 levels in the nigrostriatal tract. However, MPTP did not affect the coenzyme Q content in the cerebellum, cortex and pons. This study demonstrated that MPP(+)/MPTP significantly affected the coenzyme Q content in the SH-SY5Y and NG-108 cells and in the mouse nigrostriatal tract.
- Published
- 2008
- Full Text
- View/download PDF
41. Role of lipoamide dehydrogenase and metallothionein on 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced neurotoxicity.
- Author
-
Dhanasekaran M, Albano CB, Pellet L, Karuppagounder SS, Uthayathas S, Suppiramaniam V, Brown-Borg H, and Ebadi M
- Subjects
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism, 1-Methyl-4-phenylpyridinium metabolism, 1-Methyl-4-phenylpyridinium pharmacology, Animals, Calcium metabolism, Copper metabolism, Corpus Striatum metabolism, Dose-Response Relationship, Drug, Mice, Mice, Inbred C57BL, Zinc metabolism, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine pharmacology, Dihydrolipoamide Dehydrogenase metabolism, Metallothionein metabolism, Neurons drug effects, Neurotoxins pharmacology
- Abstract
In the present study, we investigated the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on lipoamide dehydrogenase activity and metallothionein content. Lipoamide dehydrogenase is a flavoprotein enzyme, which reduces lipoamide and low molecular weight thiols. This enzyme has also been involved in the conversion of ubiquinone (coenzyme Q-10, oxidized form) to ubiquinol (reduced form). Lipoamide dehydrogenase activity was measured spectrophotometrically following its incubation with different doses of MPTP, MPP+, and divalent metals. MPTP at higher concentrations inhibited the lipoamide dehydrogenase activity, whereas it's potent toxic metabolite 1-methyl-4-phenylpyridinium (MPP+) had a similar effect at lower concentration. Calcium and copper did not affect the enzyme activity at any of the doses tested, whereas, zinc dose dependently enhanced the lipoamide dehydrogenase activity. Additionally, levels of metallothionein in the mouse nigrostriatal system were measured by cadmium affinity method following administration of MPTP. Metallothionein content was significantly reduced in the substantia nigra (SN), and not in the nucleus caudatus putamen (NCP) following a single administration of MPTP (30 mg/kg, i.p.). Our results suggests that both lipoamide dehydrogenase activity and metallothionein levels may be critical for dopaminergic neuronal survival in Parkinson's disease and provides further insights into the neurotoxic mechanisms involved in MPTP-induced neurotoxicity.
- Published
- 2008
- Full Text
- View/download PDF
42. Hippocampus of Ames dwarf mice is resistant to beta-amyloid-induced tau hyperphosphorylation and changes in apoptosis-regulatory protein levels.
- Author
-
Schrag M, Sharma S, Brown-Borg H, and Ghribi O
- Subjects
- Alzheimer Disease genetics, Alzheimer Disease metabolism, Alzheimer Disease physiopathology, Amyloid beta-Peptides toxicity, Animals, Apoptosis drug effects, Apoptosis physiology, Caspase 3 drug effects, Caspase 3 metabolism, Enzyme Inhibitors pharmacology, Genetic Predisposition to Disease genetics, Glycogen Synthase Kinase 3 antagonists & inhibitors, Glycogen Synthase Kinase 3 metabolism, Glycogen Synthase Kinase 3 beta, Hippocampus physiopathology, Immunity, Innate genetics, Mice, Mice, Mutant Strains, Nerve Degeneration physiopathology, Organ Culture Techniques, Peptide Fragments toxicity, Phosphorylation drug effects, Proto-Oncogene Proteins c-bcl-2 drug effects, Proto-Oncogene Proteins c-bcl-2 metabolism, bcl-2-Associated X Protein drug effects, bcl-2-Associated X Protein metabolism, Amyloid beta-Peptides metabolism, Apoptosis Regulatory Proteins metabolism, Cytoprotection physiology, Hippocampus metabolism, Nerve Degeneration metabolism, tau Proteins metabolism
- Abstract
The Ames dwarf mouse has a long lifespan and is characterized by a marked resistance to cellular stress, an event that is implicated in the pathogenesis of many neurodegenerative disorders that are associated with aging, including Alzheimer's disease. However, very little is known on the extent to which the Ames dwarf mouse is protected against Alzheimer's disease. We have developed an organotypic slice system cultured from hippocampi of adult dwarf mice and examined deleterious effects of beta-amyloid (Abeta) peptide, a key pathogenic event in the course of Alzheimer's disease. We present the first evidence that long living Ames mice resist beta-amyloid toxicity. We demonstrate that organotypic slices from adult dwarf mice, but not their normal phenotype counterparts (wild type), are resistant to Abeta25-35-induced hyperphosphorylation of tau protein, reduction in levels of the antiapoptotic protein Bcl-2, increase in levels of the pro-apoptotic protein Bax, and activation of caspase 3. Moreover, incubation of organotypic sections with the GSK-3beta inhibitor SB216763 prevented tau phosphorylation but not alterations in levels of Bcl-2, Bax, and caspase-3. Because the hippocampus is a brain area that is severely affected in Alzheimer's disease, our study proposes that organotypic slices from hippocampi of adult Ames dwarf mice may constitute a model system for understanding endogenous factors that may confer protection against Abeta., ((c) 2007 Wiley-Liss, Inc.)
- Published
- 2008
- Full Text
- View/download PDF
43. Therapeutic efficacy of selegiline in neurodegenerative disorders and neurological diseases.
- Author
-
Ebadi M, Brown-Borg H, Ren J, Sharma S, Shavali S, El ReFaey H, and Carlson EC
- Subjects
- Animals, Humans, Nervous System Diseases drug therapy, Nervous System Diseases metabolism, Nervous System Diseases pathology, Neurodegenerative Diseases metabolism, Neurodegenerative Diseases pathology, Neurodegenerative Diseases drug therapy, Selegiline therapeutic use
- Abstract
Selegiline inhibits the activity of monoamine oxidase B, enhances the release of dopamine, blocks the uptake of dopamine, acts as a calmodulin antagonist, and enhances the level of cyclic AMP, which in turn protects dopaminergic neurons. It possesses cognition-enhancing functions, rejuvenates serum insulin-like growth factor I in aged rats, and enhances life expectancy in rodents. Selegiline possesses neurotrophic-like actions, and rescues axotomized motorneurons independent of monoamine oxidase B inhibition. It enhances the synthesis of nerve growth factor, protects dopaminergic neurons from glutamate-mediated neurotoxicity, and protects dopaminergic neurons from toxic factors present in the spinal fluid of parkinsonian patients, and the said effect may be mediated via elaborating brain derived neurotrophic factor. Selegiline increases the striatal superoxide dismutase, protects against peroxynitrite- and nitric oxide-induced apoptosis, and guards dopaminergic neurons from toxicity induced by glutathione depletion. It stimulates the biosynthesis of interleukin 1-beta and interleukin-6, is an immunoenhancing substance, possesses antiapoptotic actions, and is neuroprotectant in nature. Selegiline has been shown to be efficacious in Parkinson's disease, global ischemia, Gille de la Tourette syndrome, and narcolepsy. Its therapeutic efficacy in Alzheimer's disease remains uncertain. In Alzheimer's disease, short term studies of selegiline suggest a beneficial effect; whereas long term studies are less convincing.
- Published
- 2006
- Full Text
- View/download PDF
44. Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease.
- Author
-
Ebadi M, Brown-Borg H, El Refaey H, Singh BB, Garrett S, Shavali S, and Sharma SK
- Subjects
- Animals, Apoptosis drug effects, Brain anatomy & histology, Brain drug effects, Brain metabolism, Brain physiopathology, Coenzymes, Dopamine metabolism, Gene Expression Regulation drug effects, Gene Expression Regulation physiology, Humans, MPTP Poisoning prevention & control, Metallothionein deficiency, Mice, Mice, Neurologic Mutants physiology, Mice, Transgenic physiology, Nerve Tissue Proteins deficiency, Nerve Tissue Proteins genetics, Parkinson Disease etiology, Synucleins, Ubiquinone metabolism, alpha-Synuclein, Disease Models, Animal, Metallothionein genetics, Metallothionein therapeutic use, Parkinson Disease genetics, Parkinson Disease prevention & control, Ubiquinone analogs & derivatives
- Abstract
Parkinson's disease is characterized by a progressive loss of dopaminergic neurons in the substantia nigra zona compacta, and in other sub-cortical nuclei associated with a widespread occurrence of Lewy bodies. The cause of cell death in Parkinson's disease is still poorly understood, but a defect in mitochondrial oxidative phosphorylation and enhanced oxidative and nitrative stresses have been proposed. We have studied control(wt) (C57B1/6), metallothionein transgenic (MTtrans), metallothionein double gene knock (MTdko), alpha-synuclein knock out (alpha-syn(ko)), alpha-synuclein-metallothionein triple knock out (alpha-syn-MTtko), weaver mutant (wv/wv) mice, and Ames dwarf mice to examine the role of peroxynitrite in the etiopathogenesis of Parkinson's disease and aging. Although MTdko mice were genetically susceptible to 1, methyl, 4-phenyl, 1,2,3,6-tetrahydropyridine (MPTP) Parkinsonism, they did not exhibit any overt clinical symptoms of neurodegeneration and gross neuropathological changes as observed in wv/wv mice. Progressive neurodegenerative changes were associated with typical Parkinsonism in wv/wv mice. Neurodegenerative changes in wv/wv mice were observed primarily in the striatum, hippocampus and cerebellum. Various hallmarks of apoptosis including caspase-3, TNFalpha, NFkappaB, metallothioneins (MT-1, 2) and complex-1 nitration were increased; whereas glutathione, complex-1, ATP, and Ser(40)-phosphorylation of tyrosine hydroxylase, and striatal 18F-DOPA uptake were reduced in wv/wv mice as compared to other experimental genotypes. Striatal neurons of wv/wv mice exhibited age-dependent increase in dense cored intra-neuronal inclusions, cellular aggregation, proto-oncogenes (c-fos, c-jun, caspase-3, and GAPDH) induction, inter-nucleosomal DNA fragmentation, and neuro-apoptosis. MTtrans and alpha-Syn(ko) mice were genetically resistant to MPTP-Parkinsonism and Ames dwarf mice possessed significantly higher concentrations of striatal coenzyme Q10 and metallothioneins (MT 1, 2) and lived almost 2.5 times longer as compared to control(wt) mice. A potent peroxynitrite ion generator, 3-morpholinosydnonimine (SIN-1)-induced apoptosis was significantly attenuated in MTtrans fetal stem cells. These data are interpreted to suggest that peroxynitrite ions are involved in the etiopathogenesis of Parkinson's disease, and metallothionein-mediated coenzyme Q10 synthesis may provide neuroprotection.
- Published
- 2005
- Full Text
- View/download PDF
45. Constitutive expression of peroxisome proliferator-activated receptor alpha-regulated genes in dwarf mice.
- Author
-
Stauber AJ, Brown-Borg H, Liu J, Waalkes MP, Laughter A, Staben RA, Coley JC, Swanson C, Voss KA, Kopchick JJ, and Corton JC
- Subjects
- Animals, Base Sequence, DNA Primers, Mice, Mice, Knockout, Mice, Mutant Strains, Oligonucleotide Array Sequence Analysis, PPAR alpha deficiency, PPAR alpha genetics, Reverse Transcriptase Polymerase Chain Reaction, Dwarfism genetics, Gene Expression Regulation physiology, PPAR alpha physiology
- Abstract
Defects in growth hormone secretion or signaling in mice are associated with decreased body weights (dwarfism), increased longevity, increased resistance to stress, and decreases in factors that contribute to cardiovascular disease and cancer. Peroxisome proliferators (PP) alter a subset of these changes in wild-type mice through activation of the nuclear receptor family member PP-activated receptor alpha (PPARalpha). We tested the hypothesis that an overlap in the transcriptional programs between untreated dwarf mice and PP-treated wild-type mice underlies these similarities. Using transcript profiling, we observed a statistically significant overlap in the expression of genes differentially regulated in control Snell dwarf mice (Pit-1dw) compared with phenotypically normal heterozygote (+/dw) control mice and those altered by the PP 4-chloro-6-(2,3-xylidino)-2-pyrimidinyl)thioacetic acid (WY-14,643) in +/dw mice. The genes included those involved in beta- and omega-oxidation of fatty acids (Acox1, Cyp4a10, Cyp4a14) and those involved in stress responses (the chaperonin, T-complex protein1epsilon) and cardiovascular disease (fibrinogen). The levels of some of these gene products were also altered in other dwarf mouse models, including Ames, Little, and growth hormone receptor-null mice. The constitutive increases in PPARalpha-regulated genes may be partly caused by increased expression of PPARalpha mRNA and protein as observed in the livers of control Snell dwarf mice. These results indicate that some of the beneficial effects associated with the dwarf phenotype may be caused by constitutive activation of PPARalpha and regulated genes.
- Published
- 2005
- Full Text
- View/download PDF
46. Peroxynitrite in the pathogenesis of Parkinson's disease and the neuroprotective role of metallothioneins.
- Author
-
Ebadi M, Sharma SK, Ghafourifar P, Brown-Borg H, and El Refaey H
- Subjects
- Animals, Cell Line, DNA, Complementary, Glutathione metabolism, Humans, Mice, Microscopy, Fluorescence, Oligonucleotide Array Sequence Analysis, Oxidative Stress, Metallothionein physiology, Neuroprotective Agents, Parkinson Disease physiopathology, Peroxynitrous Acid physiology
- Abstract
Parkinson's disease (PD) is characterized by a progressive loss of dopaminergic neurons in the substantia nigra zona compacta and in other subcortical nuclei associated with a widespread occurrence of Lewy bodies. The causes of cell death in Parkinson's disease are still poorly understood, but a defect in mitochondrial oxidative phosphorylation and enhanced oxidative stress has been proposed. We have examined 3-morpholinosydnonimine (SIN-1)-induced apoptosis in control and metallothionein-overexpressing dopaminergic neurons, with a primary objective to determine the neuroprotective potential of metallothionein (MT) against peroxynitrite-induced neurodegeneration in PD. SIN-1 induced lipid peroxidation and triggered plasma membrane blebbing. In addition, it caused DNA fragmentation, alpha-synuclein induction, and intramitochondrial accumulation of metal ions (copper, iron, zinc, and calcium), and it enhanced the synthesis of 8-hydroxy-2-deoxyguanosine. Furthermore, it downregulated the expression of Bcl-2 and poly(adenosine diphosphate-ribose) polymerase, but upregulated the expression of caspase-3 and Bax in dopaminergic (SK-N-SH) neurons. SIN-1 induced apoptosis in aging mitochondrial genome knockout cells, alpha-synuclein-transfected cells, metallothionein double-knockout cells, and caspase-3-overexpressed dopaminergic neurons. SIN-1-induced changes were attenuated with selegiline or in metallothionein-transgenic striatal fetal stem cells. SIN-1-induced oxidation of dopamine (DA) to dihydroxyphenylacetaldehyde (DopaL) was attenuated in metallothionein-transgenic fetal stem cells and in cells transfected with a mitochondrial genome, and was enhanced in aging mitochondrial genome knockout cells, in metallothionein double-knockout cells, and caspase-3 gene-overexpressing dopaminergic neurons. Selegiline, melatonin, ubiquinone, and metallothionein suppressed SIN-1-induced downregulation of a mitochondrial genome and upregulation of caspase-3 as determined by reverse transcription polymerase chain reaction. These studies provide evidence that nitric oxide synthase activation and peroxynitrite ion overproduction may be involved in the etiopathogenesis of PD, and that metallothionein gene induction may provide neuroprotection.
- Published
- 2005
- Full Text
- View/download PDF
47. Regulation of phase I and phase II steroid metabolism enzymes by PPAR alpha activators.
- Author
-
Fan LQ, You L, Brown-Borg H, Brown S, Edwards RJ, and Corton JC
- Subjects
- Animals, Female, Male, Mice, Mice, Knockout, Microsomes, Liver drug effects, Rats, Rats, Inbred F344, Rats, Sprague-Dawley, Receptors, Cytoplasmic and Nuclear deficiency, Steroid 16-alpha-Hydroxylase metabolism, Sulfotransferases metabolism, Transcription Factors deficiency, Gonadal Steroid Hormones metabolism, Microsomes, Liver enzymology, Peroxisome Proliferators pharmacology, Receptors, Cytoplasmic and Nuclear metabolism, Transcription Factors metabolism
- Abstract
Peroxisome proliferators (PP) are a large class of structurally diverse chemicals that mediate their effects in the liver mainly through the peroxisome proliferator-activated receptor alpha (PPARalpha). Exposure to some PP results in alterations of steroid levels that may be mechanistically linked to adverse effects in reproductive organs. We hypothesized that changes in steroid levels after PP exposure are due to alterations in the levels of P450 enzymes that hydroxylate testosterone and estrogen. In testosterone hydroxylase assays, exposure to the PP, WY-14,643 (WY), gemfibrozil or di-n-butyl phthalate (DBP) led to compound-specific increases in 6beta and 16beta-testosterone and androstenedione hydroxylase activities and decreases in 16alpha, 2alpha-hydroxylase activities by all three PP. The decreases in 16alpha and 2alpha-testosterone hydroxylase activity can be attributed to a 2alpha and 16alpha- testosterone hydroxylase, CYP2C11, which we previously showed was dramatically down-regulated in these same tissues (Corton et al., 1998; Mol. Pharmacol. 54, 463-473). To explain the increases in 6beta- and 16beta-testosterone hydroxylase activities, we examined the expression of P450 family members known to carry out these functions. Alterations in the 6beta-testosterone hydroxylases CYP3A1, CYP3A2 and the 16beta-testosterone hydroxylase, CYP2B1 were observed after exposure to some PP. The male-specific estrogen sulfotransferase was down-regulated in rat liver after exposure to all PP. The mouse 6beta-testosterone hydroxylase, Cyp3a11 was down-regulated by WY in wild-type but not PPARalpha-null mice. In contrast, DEHP increased Cyp3a11 in both wild-type and PPARalpha-null mice. These studies demonstrate that PP alter the expression and activity of a number of enzymes which regulate levels of sex steroids. The changes in these enzymes may help explain why exposure to some PP leads to adverse effects in endocrine tissues that produce or are the targets of sex hormones.
- Published
- 2004
- Full Text
- View/download PDF
48. PPARalpha activators down-regulate CYP2C7, a retinoic acid and testosterone hydroxylase.
- Author
-
Fan LQ, Brown-Borg H, Brown S, Westin S, Mode A, and Corton JC
- Subjects
- Animals, Antibodies, Blocking chemistry, Biotransformation physiology, Blotting, Northern, Blotting, Western, Cytochrome P450 Family 2, Dibutyl Phthalate pharmacology, Down-Regulation drug effects, Female, Gemfibrozil pharmacology, Liver drug effects, Liver enzymology, Male, Pyrimidines pharmacology, Rats, Rats, Inbred F344, Rats, Sprague-Dawley, Sex Characteristics, Cytochrome P-450 Enzyme System metabolism, Peroxisome Proliferator-Activated Receptors physiology
- Abstract
Peroxisome proliferators (PP) are a large class of structurally diverse chemicals that mediate their effects in the liver mainly through the peroxisome proliferator-activated receptor alpha (PPARalpha). Exposure to PP results in down-regulation of CYP2C family members under control of growth hormone and sex steroids including CYP2C11 and CYP2C12. We hypothesized that PP exposure would also lead to similar changes in CYP2C7, a retinoic acid and testosterone hydroxylase. CYP2C7 gene expression was dramatically down-regulated in the livers of rats treated for 13 weeks by WY-14,643 (WY; 500 ppm) or gemfibrozil (GEM; 8000 ppm). In the same tissues, exposure to WY and GEM and to a lesser extent di-n-butyl phthalate (20,000 ppm) led to decreases in CYP2C7 protein levels in both male and female rats. An examination of the time and dose dependence of CYP2C7 protein changes after PP exposure revealed that CYP2C7 was more sensitive to compound exposure compared to other CYP2C family members. Protein expression was decreased after 1, 5 and 13 weeks of PP treatment. CYP2C7 protein expression was completely abolished at 5 ppm WY, the lowest dose tested. GEM and DBP exhibited dose-dependent decreases in CYP2C7 protein expression, becoming significant at 1000 ppm or 5000 ppm and above, respectively. These results show that PP exposure leads to changes in CYP2C7 mRNA and protein levels. Thus, in addition to known effects on steroid metabolism, exposure to PP may alter retinoic acid metabolism.
- Published
- 2004
- Full Text
- View/download PDF
49. Life extension in the dwarf mouse.
- Author
-
Bartke A and Brown-Borg H
- Subjects
- Aging physiology, Animals, Caloric Restriction, Growth Hormone deficiency, Humans, Insulin metabolism, Life Expectancy, Mice, Mice, Transgenic, Oxidative Stress, Phenotype, Prolactin deficiency, Receptor, IGF Type 1 genetics, Receptor, IGF Type 1 metabolism, Receptors, Somatotropin genetics, Receptors, Somatotropin metabolism, Reproduction physiology, Thyrotropin deficiency, Dwarfism genetics, Longevity physiology, Mice, Mutant Strains
- Abstract
Ames dwarf mice and Snell dwarf mice lack growth hormone (GH), prolactin (PRL), and thyroid-stimulating hormone (TSH), live much longer than their normal siblings, and exhibit many symptoms of delayed aging. "Laron dwarf mice," produced by targeted disruption of the GH receptor/GH-binding protein gene (GHR-KO mice), are GH resistant and also live much longer than normal animals from the same line. Isolated GH deficiency in "little" mice is similarly associated with increased life span, provided that obesity is prevented by reducing fat content in the diet. Long-lived dwarf mice share many phenotypic characteristics with genetically normal (wild-type) animals subjected to prolonged caloric restriction (CR) but are not CR mimetics. We propose that mechanisms linking GH deficiency and GH resistance with delayed aging include reduced hepatic synthesis of insulin-like growth factor 1 (IGF-1), reduced secretion of insulin, increased hepatic sensitivity to insulin actions, reduced plasma glucose, reduced generation of reactive oxygen species, improved antioxidant defenses, increased resistance to oxidative stress, and reduced oxidative damage. The possible role of hypothyroidism, reduced body temperature, reduced adult body size, delayed puberty, and reduced fecundity in producing the long-lived phenotype of dwarf mice remains to be evaluated. An important role of IGF-1 and insulin in the control of mammalian longevity is consistent with the well-documented actions of homologous signaling pathways in invertebrates.
- Published
- 2004
- Full Text
- View/download PDF
50. Mitochondrial oxidant generation and oxidative damage in Ames dwarf and GH transgenic mice.
- Author
-
Brown-Borg H, Johnson WT, Rakoczy S, and Romanick M
- Abstract
Aging is associated with an accumulation of oxidative damage to proteins, lipids and DNA. Cellular mechanisms designed to prevent oxidative damage decline with aging and in diseases associated with aging. A long-lived mouse, the Ames dwarf, exhibits growth hormone deficiency and heightened antioxidative defenses. In contrast, animals that over express GH have suppressed antioxidative capacity and live half as long as wild type mice. In this study, we examined the generation of H2O2 from liver mitochondria of Ames dwarf and wild type mice and determined the level of oxidative damage to proteins, lipids and DNA in various tissues of these animals. Dwarf liver mitochondria (24 months) produced less H2O2 than normal liver in the presence of succinate (p<0.03) and ADP (p<0.003). Levels of oxidative DNA damage (8ÕHdG) were variable and dependent on tissue and age in dwarf and normal mice. Forty-seven percent fewer protein carbonyls were detected in 24-month old dwarf liver tissue compared to controls (p<0.04). Forty percent more (p<0.04) protein carbonyls were detected in liver tissue (3-month old) of GH transgenic mice compared to wild types while 12 month old brain tissue had 53% more protein carbonyls compared to controls (p<0.005). Levels of liver malonaldehyde (lipid peroxidation) were not different at 3 and 12 months of age but were greater in Ames dwarf mice at 24 months compared to normal mice. Previous studies indicate a strong negative correlation between plasma GH levels and antioxidative defense. Taken together, these studies show that altered GH-signaling may contribute to differences in the generation of reactive oxygen species, the ability to counter oxidative stress and life span.
- Published
- 2001
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.